Health ❯ Diseases ❯ Infectious Diseases
Symptoms Transmission Treatment Drug Resistance Plasmodium falciparum Outbreaks Severe Malaria Epidemiology Prevention Strategies Diagnosis Respiratory Infections Pathogen Resistance Malaria Control Mosquito Control Malaria-protective Mutation Malaria Prevention Malaria in Africa Global Efforts Impact on Vulnerable Populations Barriers to Accessing Services Anopheles Mosquito Control Strategies Plasmodium Species Prevention and Treatment Cerebral Malaria Child Health Vaccine Deployment Plasmodium Parasites Statistics RIFIN Proteins Elimination Strategies Genetic Engineering Diagnosis and Treatment Protein Research Malaria Transmission Prevention Mosquito-borne Diseases Medical Evacuation Malaria Prevention Strategies Malaria Vaccine Development Prevention Methods Research Funding and Control Plasmodium berghei Prevention and Control Prevention South Sudan Artemisinin Resistance Mortality Rates Global Malaria Situation Hemorrhagic Fever
The ganaplacide–lumefantrine combo could reach patients in roughly 12 to 18 months if regulators grant approval.
